Efficacy of the Act of Urination to Relief the Pain During Flexible Cystoscopy Procedure.

NCT ID: NCT05207969

Last Updated: 2022-01-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

58 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-08-01

Study Completion Date

2022-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research is about modification during routine cystoscopy (scope in the bladder) procedure \[ experimental research \]. The goal of the study is to evaluate patient experience with cystoscopy by using procedural modification to reduce pain perception. The investigator aim for quality improvement of the current methods of cystoscopy to achieve a better patient experience.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study Area

-Department of Urology, Hospital Universiti Sains Malaysia.

Study population. -Patient who is required for flexible cystoscopy procedure attending Urology Unit in Hospital USM

Participants

Inclusion Criteria :

• Adult (\>18 years old)

Exclusion criteria:

* Analgesic use within 24hours
* History of stricture ,urinary tract infection, existing urethral pain
* Secondary procedure(example stent, stone removal, fulguration)

Withdrawal Criteria

* Change of mind
* Found to be outside the parameters of inclusion criteria, and inside the parameters of exclusion criteria
* Breach of Protocol

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hematuria Bladder Ca Bladder Stone Urologic Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Arm

Cystoscopy procedure will be done based on cystoscopy protocol. During scope procedure patient will not giving instruction to urinate during the procedure.

Group Type NO_INTERVENTION

No interventions assigned to this group

Experimental Arm

Cystoscopy procedure will be done based on cystoscopy protocol. During scope procedure, patient will be ask to urinate and this will lead to contraction of urinary bladder and relaxation of external urethral sphincter. Scope will then pass through external urethral sphinter and go to the urinary bladder

Group Type EXPERIMENTAL

Instruction to urinate

Intervention Type PROCEDURE

Cystoscopy procedure will be done based on cystoscopy protocol. During scope procedure, patient will be ask to urinate and this will lead to contraction of urinary bladder and relaxation of external urethral sphincter. Scope will then pass through external urethral sphinter and go to the urinary bladder

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Instruction to urinate

Cystoscopy procedure will be done based on cystoscopy protocol. During scope procedure, patient will be ask to urinate and this will lead to contraction of urinary bladder and relaxation of external urethral sphincter. Scope will then pass through external urethral sphinter and go to the urinary bladder

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

voiding instruction

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age more 18 years old

Exclusion Criteria

* Analgesic use within 24hours
* History of stricture ,urinary tract infection, existing urethral pain
* Secondary procedure(exp stent, stone removal, fulguration)
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universiti Sains Malaysia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Munawwar Bin Mohd Adnan

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MUNAWWAR BIN ADNAN DR, MD

Role: PRINCIPAL_INVESTIGATOR

HUSM

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital University Sains Malaysia

Kota Bharu, Kelantan, Malaysia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Malaysia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

MUNAWWAR ADNAN DR, MD

Role: CONTACT

+60174388516

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

MUNAWWAR BIN MOHD ADNAN, MD

Role: primary

0174388516

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HUSMKK

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.